StockData
Rezolute, Inc. logo

Rezolute, Inc. (RZLT) shareholders

RZLTNasdaqPharmaceutical PreparationsFiscal year ends June 30
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$4.25+0.24 (+5.85%)

Close on Nov 18, 2026Market cap $411.07MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
89.6%
87M of 97M shares
Institutional holders
144
39 new, 19 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
10 buys · 0 sales
Net bought $289.05K

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
RA Capital Healthcare Fund, L.P.
Joint filing with RA Capital Management, L.P. (9.90%), Peter Kolchinsky (9.90%) and 1 more
15,302,1869.90%13G (passive)Dec 11, 2025
FMR LLC
Joint filing with Abigail P. Johnson (15.00%)
12,811,87615.00%13G (passive) amendmentJun 30, 2025
Voting Shares Irrevocable Trust
Joint filing with Federated Hermes, Inc. (19.99%), Thomas R. Donahue (19.99%) and 2 more
8,250,27419.99%13G (passive) amendmentDec 31, 2023
James Silverman
Joint filing with Opaleye Management Inc. (6.58%), Opaleye, L.P. (6.44%)
6,300,0006.58%13G (passive) amendmentMar 31, 2026
Dellora Investments LP
Joint filing with Kevin Pyun (5.90%), Dellora Investments Master Fund LP (5.10%)
5,721,8345.90%13G (passive)Aug 5, 2026
Jennison Associates LLC5,332,0685.50%13G (passive)Sep 30, 2026
Dmitry Balyasny
Joint filing with Balyasny Asset Management L.P. (5.28%), Bam Gp LLC (5.28%) and 2 more
5,048,4215.28%13G (passive)Mar 31, 2026
Wilmot B. Harkey
Joint filing with Nantahala Capital Management, LLC (8.60%), Daniel Mack (8.60%)
4,966,7178.60%13G (passive) amendmentSep 30, 2024
Opaleye Management Inc.
Joint filing with James Silverman (5.30%), Opaleye, L.P. (5.16%)
4,912,9005.30%13G (passive)Dec 12, 2025
BlackRock, Inc.4,881,5095.40%13G (passive)Sep 30, 2025
Raymond Debbane4,870,0005.40%13G (passive)Sep 18, 2025

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of RZLTValueChange% of portfolio
Federated Hermes, Inc.12,990,65913.43%$67.55M–0.10%
Ra Capital Management, L.P.9,445,0399.77%$49.11M+265,0390.43%
BlackRock, Inc.7,718,2917.98%$40.14M+1,404,7880.00%
Opaleye Management Inc.6,300,0006.51%$32.76M–2.97%
Balyasny Asset Management L.P.4,662,0394.82%$24.24M−386,3820.03%
Vanguard Capital Management LLC3,835,8273.97%$19.95M+313,7470.00%
Siren, L.L.C.3,328,2873.44%$17.31M–0.35%
Jacobs Levy Equity Management, Inc2,561,6542.65%$13.32M+2,341,2470.05%
Jennison Associates LLC2,459,3082.54%$12.79M−979,5730.01%
Geode Capital Management, LLC2,170,1542.24%$11.29M+205,7950.00%
State Street Corp1,850,1281.91%$9.62M+78,2870.00%
D. E. Shaw & Co., Inc.1,839,3571.90%$9.56M+73,3770.00%
Morgan Stanley1,618,7831.67%$8.42M−1,128,8880.00%
Vanguard Portfolio Management LLC1,380,7461.43%$7.18M−1,601,0190.00%
Goldman Sachs Group Inc1,316,7821.36%$6.85M+714,4860.00%
Nuveen, LLC1,295,2091.34%$6.74M+1,197,5230.00%
Kennedy Capital Management LLC1,221,6781.26%$6.35M−14,4200.11%
Blackstone Inc.1,082,9271.12%$5.63MNew0.02%
Aqr Capital Management LLC1,007,9621.04%$5.24M+211,2660.00%
Affinity Asset Advisors, LLC1,000,0001.03%$5.20M−547,6410.24%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202614487M89.6%39 / 6029 / 1913M13M
Q1 202612586M89.2%34 / 3739 / 3022M21M
Q4 202512290M93.5%41 / 4425 / 3442M38M
Q3 202511687M89.9%35 / 3929 / 1118M9M
Q2 20259278M80.6%43 / 3313 / 2839M6M
Q1 20257745M46.6%18 / 3118 / 1211M9M
Q4 20247143M44.7%22 / 2319 / 99M3M
Q3 20245939M40.2%19 / 2010 / 114M7M
Q2 20245243M44.0%24 / 186 / 516M1M
Q1 20243327M28.0%8 / 96 / 73M6M
Q4 20233230M31.5%4 / 115 / 29M2M
Q3 20233024M24.7%2 / 410 / 10M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

140 funds held RZLT in Q2 2026, 33% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of RZLTValue% of fundAs of
Federated Hermes Kaufmann Fund7,484,0007.74%$35.32M0.72%Jul 31, 2026
Federated Hermes Kaufmann Small Cap Fund5,340,8605.52%$25.21M0.89%Jul 31, 2026
Vanguard Total Stock Market Index Fund2,744,6472.84%$14.27M0.00%Jun 30, 2026
iShares Russell 2000 ETF2,065,7332.14%$10.74M0.01%Jun 30, 2026
Vanguard Extended Market Index Fund1,005,7321.04%$5.23M0.01%Jun 30, 2026
Fidelity Small Cap Index Fund856,7110.89%$4.04M0.01%Jul 31, 2026
iShares Russell 2000 Value ETF636,9800.66%$3.31M0.02%Jun 30, 2026
Vanguard Strategic Small-Cap Equity Fund629,4530.65%$3.27M0.10%Jun 30, 2026
Fidelity Extended Market Index Fund450,6540.47%$1.49M0.00%May 31, 2026
Schwab U.S. Small-Cap ETF411,5710.43%$1.36M0.01%May 31, 2026
Vanguard Russell 2000 Index Fund372,3220.38%$1.23M0.01%May 31, 2026
Janus Henderson Small Cap Growth Alpha ETF320,8550.33%$1.51M0.42%Jul 31, 2026
Dimensional U.S. Small Cap ETF319,9260.33%$1.51M0.01%Jul 31, 2026
iShares Micro-Cap ETF263,1850.27%$1.37M0.09%Jun 30, 2026
College Retirement Equities Fund - Total Global Stock Account239,0400.25%$1.24M0.00%Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Nevan C. ElamCEO, Director605,4970.63%Jul 7, 2026
Daron EvansCFO477,4000.49%Oct 23, 2026
Sunil Ratilal KarnawatChief Commercial Officer79,1730.08%Sep 3, 2026
Brian Kenneth RobertsChief Medical Officer309,3510.32%Jul 7, 2026
Wladimir HogenhuisDirector119,6750.12%Dec 17, 2025
Philippe FauchetDirector55,5000.06%Nov 21, 2025
Nerissa KreherDirector58,5760.06%Nov 21, 2025
Gil M. LabrucherieDirector109,0720.11%Nov 21, 2025
Young-Jin KimDirector8,594,3368.89%Nov 21, 2025
Erik HarrisDirector21,0000.02%Nov 21, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Daron Evans
CFO
Oct 21, 2026Gift+4,000––11,000
Daron Evans
CFO
Oct 21, 2026Gift+4,000––11,000
Daron Evans
CFO
Oct 21, 2026Gift−16,000––395,400
Sunil Ratilal Karnawat
Chief Commercial Officer
Sep 2, 2026Tax withholding−2,267$4.50$10.20K69,275
Daron Evans
CFO
Jul 2, 2026Tax withholding−3,062$4.99$15.28K411,400
Brian Kenneth Roberts
Chief Medical Officer
Jul 2, 2026Tax withholding−3,062$4.99$15.28K293,851
Nevan C. Elam
CEO, Director
Jul 2, 2026Tax withholding−8,004$4.99$39.94K605,497
Daron Evans
CFO
Mar 30, 2026Buy+10,000$2.85$28.50K414,462
Nevan C. Elam
CEO, Director
Mar 2, 2026Tax withholding−27,618$2.99$82.58K613,501
Brian Kenneth Roberts
Chief Medical Officer
Mar 2, 2026Tax withholding−11,439$2.99$34.20K296,913
Daron Evans
CFO
Mar 2, 2026Tax withholding−11,438$2.99$34.20K404,462
Brian Kenneth Roberts
Chief Medical Officer
Dec 16, 2025Buy+28,000$1.70$47.60K308,352
Wladimir Hogenhuis
Director
Dec 16, 2025Buy+5,650$1.69$9.55K119,675
Daron Evans
CFO
Dec 15, 2025Buy+2,500$1.79$4.48K7,000
Daron Evans
CFO
Dec 15, 2025Buy+2,500$1.79$4.48K7,000
Daron Evans
CFO
Dec 15, 2025Buy+40,000$1.77$70.80K415,900
Sunil Ratilal Karnawat
Chief Commercial Officer
Dec 15, 2025Buy+12,000$1.62$19.44K71,442
Sunil Ratilal Karnawat
Chief Commercial Officer
Dec 15, 2025Buy+100$1.60$16071,542
Nevan C. Elam
CEO, Director
Dec 15, 2025Buy+32,000$1.59$50.88K641,119
Daron Evans
CFO
Dec 9, 2025Buy+10,549$5.04$53.17K131,900
Young-Jin Kim
Director
Nov 19, 2025Award+21,000––170,950
Nerissa Kreher
Director
Nov 19, 2025Award+21,000––58,576
Wladimir Hogenhuis
Director
Nov 19, 2025Award+21,000––114,025
Nevan C. Elam
CEO, Director
Nov 19, 2025Award+317,000––609,119
Gil M. Labrucherie
Director
Nov 19, 2025Award+21,000––55,500
Brian Kenneth Roberts
Chief Medical Officer
Nov 19, 2025Award+123,000––280,352
Philippe Fauchet
Director
Nov 19, 2025Award+21,000––55,500
Sunil Ratilal Karnawat
Chief Commercial Officer
Nov 19, 2025Award+32,000––59,442
Daron Evans
CFO
Nov 19, 2025Award+107,000––375,900
Erik Harris
Director
Nov 19, 2025Award+21,000––21,000
Sunil Ratilal Karnawat
Chief Commercial Officer
Aug 18, 2025Award+25,000––27,442
Brian Kenneth Roberts
Chief Medical Officer
Jun 25, 2025Buy+2,500$4.38$10.95K15,500
Daron Evans
CFO
Jun 24, 2025Buy+5,000$4.05$20.25K268,900
Young-Jin Kim
Director
Jun 13, 2025Buy+1,230,769$3.25$4.00M8,423,386
Nerissa Kreher
Director
Jun 13, 2025Buy+3,076$3.25$10.00K37,576
Wladimir Hogenhuis
Director
Jun 10, 2025Award+9,000––93,025
Gil M. Labrucherie
Director
Jun 10, 2025Award+9,000––34,500
Nerissa Kreher
Director
Jun 10, 2025Award+9,000––34,500
Nevan C. Elam
CEO, Director
Jun 10, 2025Award+68,000––292,119
Daron Evans
CFO
Jun 10, 2025Award+26,000––263,900
Philippe Fauchet
Director
Jun 10, 2025Award+9,000––34,500
Brian Kenneth Roberts
Chief Medical Officer
Jun 10, 2025Award+26,000––157,352
Young-Jin Kim
Director
Jun 10, 2025Award+9,000––149,950
Wladimir Hogenhuis
Director
Mar 31, 2025Buy+6,758$2.92$19.73K84,025
Nevan C. Elam
CEO, Director
Mar 27, 2025Buy+12,302$2.85$35.06K224,119
Daron Evans
CFO
Mar 26, 2025Buy+10,000$2.88$28.80K23,000
Daron Evans
CFO
Mar 26, 2025Buy+10,000$2.89$28.90K237,900
Wladimir Hogenhuis
Director
Feb 18, 2025Buy+10,000$4.70$47.00K77,267
Wladimir Hogenhuis
Director
Feb 16, 2025Award+25,500––67,267
Gil M. Labrucherie
Director
Feb 16, 2025Award+25,500––25,500
Young-Jin Kim
Director
Feb 16, 2025Award+25,500––140,950
Nerissa Kreher
Director
Feb 16, 2025Award+25,500––25,500
Nevan C. Elam
CEO, Director
Feb 16, 2025Award+204,000––211,817
Philippe Fauchet
Director
Feb 16, 2025Award+25,500––25,500
Daron Evans
CFO
Feb 16, 2025Award+77,000––227,900
Brian Kenneth Roberts
Chief Medical Officer
Feb 16, 2025Award+77,000––131,352
Daron Evans
CFO
Dec 18, 2024Buy+10,000$4.29$42.90K150,900
Daron Evans
CFO
Dec 12, 2024Buy+9,000$4.60$41.40K140,900
Wladimir Hogenhuis
Director
Sep 24, 2024Buy+4,259$4.70$20.02K41,767
Young-Jin Kim
Director
Jun 25, 2024Buy+1,250,000$4.00$5.00M7,192,617

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
21.44%
18M shares short
Days to cover
14.9
At 1M shares a day
Change since last report
-3.5%
From 19M shares
Short volume, 20 days
39.4%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Rezolute's stock actually held short. Settlement fails (shares not delivered on time) peaked at 98,801 shares on Aug 26, 2026 over the last 90 days.

See a number that looks wrong?